Drugs / VRC-ZKADNA085-00-VP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02840487 | Aug 2016 → Mar 2019 | Zika virus infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VRC-ZKADNA085-00-VP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02840487 ↗ |
| Modality | Vaccine | “ZIKV DNA vaccine” NCT02840487 ↗ |
| Route | Intramuscular | “administered as an intramuscular (IM) injection in the deltoid muscle.” NCT02840487 ↗ |